LDLRAD3 and non-small cell lung carcinoma: Similarly, LDLRAD3-low group mostly increased cytokines, HLA molecules and immune checkpoints compared to LDLRAD3-high group, suggesting that LDLRAD3 play an immunosuppressive role in TME of NSCLC (Figure S2B).